Michael E Williams, MD
Hematologic Malignancy
Bio & Overview
Dr. Michael E. Williams is the Byrd S. Leavell professor of medicine and professor of pathology at UVA School of Medicine.
Dr. Williams received his MD from the University of Cincinnati College of Medicine and a master of science from the Harvard School of Public Health. He completed his medicine residency, chief residency and fellowship in hematology/oncology at the UVA Health in Charlottesville.
Dr. Williams’ research interests are in novel therapeutic approaches for non-Hodgkin lymphomas, mantle cell lymphoma and CLL, including targeted agents and immunotherapeutics. He serves on the scientific advisory board of the Lymphoma Research Foundation, and is a member of the European Mantle Cell Lymphoma Network and the Eastern Cooperative Oncology Group Lymphoma Core Committee. He is a former chair of the Hematology Subspecialty Board of the American Board of Internal Medicine.
He participates regularly in national and international programs devoted to education and research in lymphoma, CLL and other hematologic malignancies.
- Gender
- Male
- Languages
- English
- Age Groups Seen
- Adults (21-65)
Older Adults (65+)
- Primary Education
- University of Cincinnati College of Medicine (1979)
- Residency
- University of Virginia Medical Center (1983)
- Fellowship
- University of Virginia Medical Center (1986)
- Certification
- American Board of Internal Medicine (Hematology), American Board of Internal Medicine (Medical Oncology), American Board of Internal Medicine (Internal Medicine)
- Appointment
- Physician Lead - Cancer Service Line, UVA Health System, Associate Director - Clinical Affairs, UVA Cancer Center
Highlights
Dr. Michael Williams profile video
My name is Michael Williams. I'm an attending physician in Hematology and Medical Oncology at the University of Virginia. My main areas of focus are in lymphoma, both non-Hodgkin lymphoma and Hodgkin disease, as well as leukemias, in particular, chronic lymphocytic leukemia. Our focus here is both on state-of-the-art care for these complex diseases, and also with clinical investigation, and bringing new and very promising treatments to our patients. Patients coming to the university for the first time can expect that they will be seeing individuals and teams that focus in their disease, whether it's lung cancer or breast cancer or lymphoma, or multiple myeloma, or non-malignant blood disorders. We have expertise here both at the attending physician level and at the diagnostic and patient care levels throughout the cancer center. Our aim is to have the experience here, from beginning to completion of treatment, to be just as seamless and comprehensive as it can be.
Awards
- 2021 Mantle Cell Lymphoma Leadership Award, Lymphoma Research Foundation
- 2019 Best Bedside Manner Awards, OurHealth Charlottesville and Shenandoah Valley Magazine; Honorable Mention, Hematology/Oncology
- 2018 Best Bedside Manner Awards, OurHealth Charlottesville and Shenandoah Valley Magazine; First Place, Hematology/Oncology
- 2011-2020 Best Doctors in America® List
- 2015 One of America's Top Cancer Doctors, Newsweek®
- Top Doctors in America
- America’s Top Doctors for Cancer